Pharming Group N.V. (PHAR)

NASDAQ: PHAR · Real-Time Price · USD

10.08

-0.67 (-6.23%)

At close: Jul 31, 2026, 4:00 PM EDT

10.21

+0.13 (1.29%)

After-hours: Jul 31, 2026, 7:34 PM EDT

Pharming Group Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	276.25	376.13	297.2	245.32	205.62	198.87
Revenue Growth	-	26.56%	21.15%	19.30%	3.40%	-6.27%
Gross Profit	317.1	330.63	261.8	220.1	188.06	177.73
Operating Income	17.09	25.84	-8.62	-5.39	18.23	13.56
Net Income	9.19	2.85	-11.84	-10.55	13.67	16
Earnings Per Share	0.12	0.04	-0.18	-0.16	0.19	0.23
EPS Growth	-	-	-	-	-17.39%	-58.18%

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Ruconest®	317.92	252.24	227.13	205.62
Joenja®	58.21	44.96	18.18	-
Total	376.13	297.2	245.32	205.62

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	158.28	179.1	167.89	213.42	207.34	191.92
Total Debt	113.3	115.78	112.31	171.55	166.69	161.93
Net Cash (Debt)	44.99	63.33	55.58	41.88	40.65	30
Net Cash Growth	-	13.94%	32.72%	3.03%	35.50%	66.77%
Net Cash Per Share	0.60	0.85	0.71	0.58	0.57	0.43

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	35.03	54.71	-1.8	-17.3	22.46	37.84
Capital Expenditures	-0.66	-0.75	-0.79	-1.44	-1.38	-10.74
Free Cash Flow	34.37	53.96	-2.59	-18.74	21.08	27.1
Free Cash Flow Growth	14.02%	-	-	-	-22.21%	-65.68%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	114.79%	87.90%	88.09%	89.72%	91.46%	89.37%
Operating Margin	6.19%	6.87%	-2.90%	-2.20%	8.87%	6.82%
Pretax Margin	5.70%	3.42%	-2.86%	-4.90%	7.29%	11.60%
Profit Margin	3.33%	0.67%	-3.98%	-4.30%	6.65%	8.04%
FCF Margin	12.44%	14.35%	-0.87%	-7.64%	10.25%	13.63%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	76.88	441.75	-	-	58.05	38.87
P/FCF Ratio	20.81	22.98	-	-	34.34	21.40
PS Ratio	1.95	3.30	2.31	3.13	3.52	2.92